Categories: News

RadNet, Inc. to Present at the BofA Securities 2022 Leveraged Finance Conference on November 29, 2022

LOS ANGELES, Nov. 25, 2022 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the BofA Securities 2022 Leveraged Finance Conference in Boca Raton, FL on Tuesday, November 29, 2022 at 11:50 a.m. Pacific Time (2:50 p.m. Eastern Time)  

There will be simultaneous and archived webcasts available at https://bofa.veracast.com/webcasts/bofa/levfin2022/id98U5UR.cfm

and www.radnet.com under the “About RadNet” menu section and “News and Press Releases” sub-menu of the website.

Details for RadNet’s Presentation:
Date: Tuesday, November 29, 2022
Time: 11:50 a.m. Pacific Time (2:50 p.m. Eastern Time)
Location: Boca Raton Resort, Boca Raton, FL

About RadNet, Inc.

RadNet, Inc., is the leading national provider of freestanding, fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 349 owned and/or operated outpatient imaging centers. RadNet’s markets include Arizona, California, Delaware, Florida, Maryland, New Jersey and New York. Together with affiliated radiologists, inclusive of full-time and per diem employees and technologists, RadNet has a total of approximately 9,000 employees. For more information, visit http://www.radnet.com.

CONTACT:

RadNet, Inc.

Mark Stolper, 310-445-2800

Executive Vice President and Chief Financial Officer

Staff

Recent Posts

Signifier Medical Technologies’ eXciteOSA Now Covered by Medicaid in South Carolina: Reaching a Wider Patient Population with Daytime Sleep Apnea Therapy

BOSTON--(BUSINESS WIRE)--Signifier Medical Technologies Limited (“Signifier”), a leader in medical technology for sleep-disordered breathing, is…

2 hours ago

Thryv Therapeutics Inc. Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference

Montreal, Quebec--(Newsfile Corp. - April 4, 2024) - Thryv Therapeutics Inc., a Montreal based biotechnology…

2 hours ago

MMJ BioPharma Cultivation Sues the DEA once again – Is the DEA a Rogue Agency?

The DEA Games Continue To Delay Legitimate Marijuana Clinical Trials and ResearchWASHINGTON, DC / ACCESSWIRE…

2 hours ago

Oral Cancer Cause Joins with the V Foundation for Cancer Research

LARGO, FL / ACCESSWIRE / April 4, 2024 / Oral Cancer Cause (OCC), a non-profit…

2 hours ago

Annual Report 2023

GOTHENBURG, SWEDEN / ACCESSWIRE / April 4, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Today XVIVO Perfusion…

2 hours ago

New Life Solutions Addresses Florida Court Decision to Bring Major Changes to Abortion Laws

TAMPA, FL / ACCESSWIRE / April 4, 2024 / On April 1, 2024, the Florida…

2 hours ago